213 related articles for article (PubMed ID: 20147618)
1. Clinical pharmacokinetics of pregabalin in healthy volunteers.
Bockbrader HN; Radulovic LL; Posvar EL; Strand JC; Alvey CW; Busch JA; Randinitis EJ; Corrigan BW; Haig GM; Boyd RA; Wesche DL
J Clin Pharmacol; 2010 Aug; 50(8):941-50. PubMed ID: 20147618
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures.
Bockbrader HN; Burger P; Knapp L; Corrigan BW
Epilepsia; 2011 Feb; 52(2):248-57. PubMed ID: 21269291
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin pharmacology and its relevance to clinical practice.
Ben-Menachem E
Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of single-dose intragastric and intravenous pregabalin administration in clinically normal horses.
Mullen KR; Schwark W; Divers TJ
Am J Vet Res; 2013 Jul; 74(7):1043-8. PubMed ID: 23802677
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of pregabalin in subjects with various degrees of renal function.
Randinitis EJ; Posvar EL; Alvey CW; Sedman AJ; Cook JA; Bockbrader HN
J Clin Pharmacol; 2003 Mar; 43(3):277-83. PubMed ID: 12638396
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of single-dose oral pregabalin administration in normal dogs.
Salazar V; Dewey CW; Schwark W; Badgley BL; Gleed RD; Horne W; Ludders JW
Vet Anaesth Analg; 2009 Nov; 36(6):574-80. PubMed ID: 19845930
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.
Bockbrader HN; Wesche D; Miller R; Chapel S; Janiczek N; Burger P
Clin Pharmacokinet; 2010 Oct; 49(10):661-9. PubMed ID: 20818832
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.
Chew ML; Plotka A; Alvey CW; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
Clin Drug Investig; 2014 Sep; 34(9):617-26. PubMed ID: 25078976
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studies.
Chew ML; Alvey CW; Plotka A; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
Clin Drug Investig; 2014 Sep; 34(9):627-37. PubMed ID: 25078977
[TBL] [Abstract][Full Text] [Related]
12. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
Stampfuss J; Kubitza D; Becka M; Mueck W
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food.
Chen C; Cowles VE; Hou E
J Clin Pharmacol; 2011 Mar; 51(3):346-58. PubMed ID: 20484610
[TBL] [Abstract][Full Text] [Related]
15. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
16. [Pregabalin (Lyrica) and neuropathic pain syndromes].
Jacquy J; Lossignol D; Sternon J
Rev Med Brux; 2006; 27(5):445-50. PubMed ID: 17144644
[TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
[TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study.
Mann D; Liu J; Chew ML; Bockbrader H; Alvey CW; Zegarac E; Pellock J; Pitman VW
Epilepsia; 2014 Dec; 55(12):1934-43. PubMed ID: 25377429
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects.
Li Z; TenHoor C; Marbury T; Swan S; Ticho B; Rogge M; Nestorov I
J Clin Pharmacol; 2011 Jul; 51(7):1004-14. PubMed ID: 20926751
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence assessment of a pregabalin capsule and oral solution in fasted healthy volunteers: a randomized, crossover study.
Bockbrader HN; Alvey CW; Corrigan BW; Radulovic LL
Int J Clin Pharmacol Ther; 2013 Mar; 51(3):244-8. PubMed ID: 23357837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
